Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

JCC Plus, 2026
Altered Levels of Enteric Glial Cells and Their Associated Pro‐Inflammatory Proteins in Patients With Ulcerative Colitis During Active Disease Compared to Remission and Healthy Controls

Beaudeau J., Katinios G., Lindqvist C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyTissue Lysate

Medicine, 2026
Osteochondrosis and osteomalacia are distinguished by inflammatory factors and metabolites

Chen J., Liu Y., Chen J. et al.

Olink Target 96OrthopedicsPathophysiologyPatient StratificationPlasma

Journal of Proteome Research, 2026
Plasma Proteomic Signatures of Accelerometer-Measured Sedentary Behavior Are Associated with Future Disease Risk

Dai S., Chen Y., Huang S. et al.

Olink Explore 3072/384Wider Proteomics StudiesPatient StratificationPlasma

Frontiers in Immunology, 2026
Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection

Fineschi S., Klar J., Schuster J. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Research, 2026
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

Olink Target 96OncologyHepatologyPathophysiologyPlasma

eJHaem, 2026
Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP‐4 as Diagnostic and Predictive Biomarkers

Hedberg G., Chen Q., Lakshmikanth T. et al.

Olink Target 96OncologyHematologyPediatricsPatient StratificationPlasma

Preventive Medicine Reports, 2026
Matrix metalloproteinases and risk of cardiovascular mortality and morbidity in the United Kingdom: A prospective cohort study with machine learning analysis

Huang J., Jiang H., Lu Y. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Blood Immunology & Cellular Therapy, 2026
Identification of a plasma immune marker panel for early detection of acute graft-versus-host disease in children

Klein Lebbink W., de Koning C., Kunstek H. et al.

Olink Target 96Immunological & Inflammatory DiseasesHematologyPatient StratificationPlasma

Nature Aging, 2022
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo M., Peeters C., Johnson E. et al.

Olink Target 96Olink FocusNeurologyPathophysiologyPatient StratificationCSF

The American Journal of Emergency Medicine, 2015
Inflammatory biomarkers predicting prognosis in patients with acute dyspnea

Wiklund K., Gränsbo K., Lund N. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

The American Journal of Emergency Medicine, 2016
Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea

Lund N., Gränsbo K., Wernersson C. et al.

Olink Target 96Respiratory DiseasesPatient StratificationSerum

Nature, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes

Zou X., Hu F., Lou H. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Diabetology & Metabolic Syndrome, 2026
The role of hepatocyte growth factor in the relationship between body fat distribution and plasma markers of glucose metabolism: a cross-sectional study

Zakic K., Freuer D., Linseisen J. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

npj Science of Food, 2026
Polygonatum cyrtonema Hua fructan ameliorates ulcerative colitis via gut microbiota modulation and follistatin targeting

Xu Q., Lv Q., Yang Z. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Plasma

Maturitas, 2026
Novel proteomic subtypes of frailty with distinct molecular patterns and prognosis

Xu Z., Wang C., Wang J. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

iScience, 2026
Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

C. dos Santos J., Groenendijk A., Ruijten S. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Cancer, 2026
T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

Shan Y., Ding B., Ji F. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Communications, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank

Rioux B., McGlasson S., Forbes D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2026
Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung disease

Maddali M., Pugashetti J., Pienkos S. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

Nature Communications, 2026
AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease

Luo Y., Zhang N., Yang J. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

3606 publications